🇧🇷Brazil
HRSA Audit Failures and Required Repayments for Diversion/Duplicate Discounts
1 verified sources
Definition
HRSA conducts approximately 200 audits per year of covered entities, including retail pharmacies in 340B programs, identifying breaches like diversion of drugs to non-eligible patients or duplicate discounts. Non-compliant entities must repay discounts to manufacturers. Annual recertification and self-reporting requirements highlight recurring compliance gaps.[1]
Key Findings
- Financial Impact: $Repayment of full discounts plus potential civil monetary penalties per audit
- Frequency: Annual - ~200 audits/year by HRSA, ongoing recertification breaches
- Root Cause: Inadequate monitoring of contract pharmacy compliance, patient eligibility tracking failures, and lack of duplicate discount safeguards
Why This Matters
This pain point represents a significant opportunity for B2B solutions targeting Retail Pharmacies.
Affected Stakeholders
340B program coordinators, Pharmacy compliance teams, Finance directors
Action Plan
Run AI-powered research on this problem. Each action generates a detailed report with sources.
Methodology & Sources
Data collected via OSINT from regulatory filings, industry audits, and verified case studies.
Evidence Sources:
Related Business Risks
Diversion and Duplicate Discount Violations in Contract Pharmacies
$Repayment of discounts to manufacturers per violation
Failure to Receive 340B Ceiling Prices from Manufacturers
$Substantial savings lost (quantified as 'substantial reduction in available 340B savings') per year
Excess Labor and Overtime from Manual Compliance and Documentation Tasks
$1,000–$6,000 per store per month in additional labor and overtime associated with controlled‑substance record‑keeping and reconciliation
Delayed Reimbursement from Holds and Rejections on Controlled Substance Claims
$500–$4,000 per store per month in financing cost of delayed cash and staff time for claims follow‑up related to controlled substances
Rework and Corrective Actions from Controlled Substance Documentation Errors
$500–$3,000 per store per month in labor for rework and corrective actions, plus chain‑level project costs after adverse audit findings
Medicare Fraud Risk from Unbilled Parallel MTM Services
Full service value plus fraud penalties/repayments